Mechanisms of insulin-like growth factor regulation of programmed cell death of developing avian motoneurons.
During development of the avian neuromuscular system, lumbar spinal motoneurons (MNs) innervate their muscle targets in the hindlimb coincident with the onset and progression of MN programmed cell death (PCD). Paralysis (activity blockade) of embryos during this period rescues large numbers of MNs from PCD. Because activity blockade also results in enhanced axonal branching and increased numbers of neuromuscular synapses, it has been postulated that following activity blockade, increased numbers of MNs can gain access to muscle-derived trophic agents that prevent PCD. An assumption of the access hypothesis of MN PCD is the presence of an activity-dependent, muscle-derived sprouting or branching agent. Several previous studies of sprouting in the rodent neuromuscular system indicate that insulin-like growth factors (IGFs) are candidates for such a sprouting factor. Accordingly, in the present study we have begun to test whether the IGFs may play a similar role in the developing avian neuromuscular system. Evidence in support of this idea includes the following: (a) IGFs promote MN survival in vivo but not in vitro; (b) neutralizing antibodies against IGFs reduce MN survival in vivo; (c) both in vitro and in vivo, IGFs increase neurite growth, branching, and synapse formation; (d) activity blockade increases the expression of IGF-1 and IGF-2 mRNA in skeletal muscles in vivo; (e) in vivo treatment of paralyzed embryos with IGF binding proteins (IGF-BPs) that interfere with the actions of endogenous IGFs reduce MN survival, axon branching, and synapse formation; (f) treatment of control embryos in vivo with IGF-BPs also reduces synapse formation; and (g) treatment with IGF-1 prior to the major period of cell death (i.e., on embryonic day 6) increases subsequent synapse formation and MN survival and potentiates the survival-promoting actions of brain-derived neurotrophic factor (BDNF) and glial cell line-derived neurotrophic factor (GDNF) administered during the subsequent 4- to 5-day period of PCD. Collectively, these data provide new evidence consistent with the role of the IGFs as activity-dependent, muscle-derived agents that play a role in regulating MN survival in the avian embryo.
D'Costa
A P
AP
Department of Neurobiology and Anatomy and Neuroscience Program, Wake Forest University School of Medicine, Winston-Salem, North Carolina 27157, USA.
Prevette
D M
DM
Houenou
L J
LJ
Wang
S
S
Zackenfels
K
K
Rohrer
H
H
Zapf
J
J
Caroni
P
P
Oppenheim
R W
RW
D000818:Animals; D017209:Apoptosis / Q000502:physiology*; D002452:Cell Count; D002478:Cells, Cultured; D002642:Chick Embryo; D006614:Hindlimb / Q000294:innervation; D007150:Immunohistochemistry; D018969:Insulin-Like Growth Factor Binding Proteins / Q000494:pharmacology; D007334:Insulin-Like Growth Factor I / Q000235:genetics; D007335:Insulin-Like Growth Factor II / Q000235:genetics; D009046:Motor Neurons / Q000502:physiology*; D018482:Muscle, Skeletal / Q000196:embryology* / Q000294:innervation*; D009841:Oligonucleotides / Q000494:pharmacology; D017729:Presynaptic Terminals / Q000502:physiology; D020133:Reverse Transcriptase Polymerase Chain Reaction; D013002:Somatomedins / Q000235:genetics / Q000502:physiology*; D013569:Synapses / Q000502:physiology
D018969:Insulin-Like Growth Factor Binding Proteins; D009841:Oligonucleotides; D013002:Somatomedins; D007334:Insulin-Like Growth Factor I; D007335:Insulin-Like Growth Factor II